- $35.86bn
- $43.23bn
- $15.12bn
Kimberly-Clark offers remedies in bid for EU approval of Kenvue deal
Kimberly-Clark prepares asset sales to win EU nod for Kenvue deal, sources say
Kimberly-Clark readies asset sales in bid for EU nod for Kenvue deal, sources say
Kimberly-Clark readies EU remedies in bid for Kenvue deal, sources say
Tylenol maker, pharmacy chains urge US appeals court to revisit decision over alleged autism link
Brief: Kenvue Declares Quarterly Cash Dividend
Tylenol use in pregnancy may be linked with uterus, ovary changes in daughters (updated)
Brief: Australia's ACCC Says Kimberly-Clark’S Acquisition Of Kenvue Approved Subject To Sale Of Carefree, Stayfree Brands
Australia clears Kimberly-Clark's acquisition of Kenvue but requires Carefree, Stayfree divestment
Kimberly-Clark seeks EU approval for $40 billion Kenvue deal
Colgate Palmolive India names Kenvue's India head as new CEO (updated)
Deals of the day-Mergers and acquisitions
Brief: Essity Acquires Feminine Care Business In Brazil for $284 Million
Essity to buy Kenvue's feminine care business in Brazil for $284 million
Brief: Soros Fund Management Dissolves Share Stake In Salesforce, Cuts Share Stake in Meta, Kenvue
Brief: South Africa's Competition Tribunal Conditionally Approves Kimberly-Clark And Kenvue Deal
U.S. STOCKS ON THE MOVE-Braveheart Bio, Paysign, Hertz Global
Kenvue slips after slight quarterly miss
U.S. STOCKS ON THE MOVE-Ralph Lauren, Sempra, Parker-Hannifin, Lincoln International